Sobre mi

Antonio Alcaraz es Catedràtic d’Urologia de la Universitat de Barcelona. Des de Febrer de 2005, es Cap de Servei d’Urologia del Hospital Clínic de Barcelona. Els interessos de recerca del Dr. Alcaraz inclouen la cirurgia uro-oncològica, laparoscòpica, robòtica i de trasplantament, sen pioner en cirurgia de port únic i nefrectomia transvaginal. La major part de la seva investigación traslacional s’ha realitzat en la genética del cáncer. Es autor de més de 300 publicacions internacionals i nacionals. Ha sigut membre de la European School of Urology, I també del Scientific Committee of the European Association of Urology (2010-2016).

Publicacions destacades

  • Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group

    Autors: Gallioli A, Territo A, Boissier R, Campi R, Vignolini G, Musquera M, Alcaraz A, Decaestecker K, Tugcu V, Vanacore D, Serni S, Breda A .
    Referència: European Urology 2020.
  • Urine Gene Expression Profiles in Bladder Pain Syndrome Patients Treated with Triamcinolone

    Autors: Izquierdo L; Mateu L; Lozano JJ; Montalbo R; Ingelmo-Torres M; Gómez A; Peri L; Mengual L; Franco A; Alcaraz A.
    Referència: European Urology Focus 2020.
  • Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques

    Autors: Montalbo, Ruth; Izquierdo, Laura; Ingelmo-Torres, Mercedes; Galve, Pilar; Sole, Manel; Franco, Agustin; Jose Ribal, Maria; Alcaraz, Antonio; Mengual, Lourdes;.
    Referència: Cancer Cytopathology 2020.
  • The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guérin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Data

    Autors: Liem EIML, Oddens JR, Vernooij RWM, Li R, Kamat A, Dinney CP, Mengual L, Alcaraz A, Izquierdo L, Savic S, Thalmann GN, Bubendorf L, Sylvester RJ, de Reijke TM .
    Referència: Journal Of Urology 2020.
  • INCOMPATIBILITY LIVING DONOR KIDNEY TRANSPLANT, WHERE ABO INCOMPATIBLE, POSITIVE CROSSMATCH AND KIDNEY PAIRED DONATION TRANSPLANTS HAVE A PLACE!

    Autors: Revuelta, I; De Sousa-Amorim, E; Cucchiari, D; Lozano, M; Musquera, M; Palou, E; Valentin, MO; Ventura-Aguiar, P; Cid, J; Martorell, J; Peri, L; Garcia, M; Esforzado, N; Cofan, F; Torregrosa, JV; Piñeiro, GJ; Ugalde-Altamirano, J; Paredes, D; Adalia, R; Campistol, JM; Alcaraz, A; Oppenheimer, F; Diekmann, F.
    Referència: Transplant International 2019.
  • Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients

    Autors: Montalbo R, Lozano JJ, Izquierdo L, Ingelmo-Torres M, BaÑos C, Palou J, Van der Heijden AG, Medina R, Schmidbauer J, Prat A, Ribal MJ, Alcaraz A, Mengual L .
    Referència: Translational Research 2019.
  • Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Autors: Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ,, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium.
    Referència: Nature Communications 2018.
  • Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

    Autors: Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P,, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium.
    Referència: Nature Communications 2018.
  • Gene Expression Signature in Urine for Diagnosing and Assessing Aggressiveness of Bladder Urothelial Carcinoma

    Autors: Mengual, Lourdes; Burset, Moises; Jose Ribal, Maria; Ars, Elisabet; Marin-Aguilera, Mercedes; Fernandez, Manuel; Ingelmo-Torres, Mercedes; Villavicencio, Humberto; Alcaraz, Antonio.
    Referència: Clinical Cancer Research 2010.
  • Feasibility of Transvaginal NOTES-Assisted Laparoscopic Nephrectomy

    Autors: Alcaraz, Antonio; Peri, Lluis; Molina, Alejandro; Goicoechea, Inigo; Garcia, Eduardo; Izquierdo, Laura; Ribal, Maria J.
    Referència: European Urology 2010.

Projectes destacats

  • Valoración y acondicionamiento ex vivo de los injertos renales descartados para el trasplante mediante la máquina de perfusión normotérmica y el uso de vesículas extracelulares

    Investigador/a principal: Antonio Alcaraz Asensio
    Durada: 01/01/2022 - 31/12/2024
  • Identificación de biomarcadores pronósticos del tumor vesical músculo invasivo y su inferencia en la biopsia líquida

    Investigador/a principal: Laura Izquierdo Reyes, Lourdes Mengual Brichs
    Finançador: Instituto de Salud Carlos III
    Codi: FIS17 - PI17/01343
    Durada: 01/01/2018 - 30/06/2021
  • Microarrays para el diagnóstico y pronóstico de los tumores de vejiga y próstata

    Finançador: Fundació Puigvert (Sede o evento)
    Durada: 01/07/2003 - 30/06/2008